References
- DeLuca H F. The metabolism, physiology, and function of vitamin D. Vitamin D: basic and clinical aspects, J Kumar. Nijhoff, The Hague 1984; 361–75
- Murdoch D, Clissold S P. Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris. Drugs 1992; 43: 415–29
- Kissmeyer A ‐M, Binderup L. Calcipotriol (MC 903): pharmacokinetics in rats and biological activities of metabolites. A comparative study with 1,25(OH)2D3. Biochem Pharmacol 1991; 41: 1601–6
- Bräutigam M, Hübner H, Rach P, et al. Effects of Calcipotriol (MC 903) and calcitriol after topical application on the skin of hairless rats. Skin Pharmacol 1992; 5: 87–92
- Reinhardt T A, Horst A L, Orf F W, et al. A microassay for 1,25‐dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. J Clin Endocrinol Metab 1984; 58: 91–8
- Langner A, Verjans H, Stapór V, et al. Topical calcitriol in the treatment of chronic plaque psoriasis: a double‐blind study. Br J Dermatol 1993; 128: 566–71
- Wishart J M. Calcitriol (1α,25‐dihydroxyvitamin D3) ointment in psoriasis, a safety tolerance and efficacy multicentre study. Dermatology 1994; 188: 135–9